share_log

复星医药:积极响应药品追溯码医保监管应用,控股医疗机构若发现重码等异常将立即报告

Fosun pharma: Actively responds to the application of pharmaceutical tracking codes in medical insurance supervision, and will immediately report any anomalies such as duplicate codes found in controlled medical institutions.

Breakings ·  Nov 16 09:37

On November 16, Fosun pharma's official WeChat account released an initiative on actively responding to the application of pharmaceutical tracking codes in medical insurance supervision, committing to fully scan all pharmaceutical tracking codes, further strengthening cooperation among upstream and downstream enterprises, and ensuring that all pharmaceutical operations enterprises collect and upload 100% of pharmaceutical tracking codes, forming an interconnected pharmaceutical tracking data chain. Fosun pharma promises that its controlled medical institutions will immediately report any anomalies such as duplicate codes found when making payments for medical insurance categories, and will refuse the outflow of pharmaceuticals with abnormal tracking codes.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment